
Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS
Late-breaking Phase III FENhance 1 and 2 study results showed superiority of investigational fenebrutinib

Late-breaking Phase III FENhance 1 and 2 study results showed superiority of investigational fenebrutinib

Study links specific cell populations to patient risk in melanoma and liver cancer In

A study led by Karl Landsteiner University shows that the disease affects whole-brain communication

An international study coordinated by the Department of Translational Medicine identifies Vitamin D-Binding Protein

Findings highlight the most effective components across different populations and contexts Extending vaccination opportunities,

Buprenorphine showed a similar to slightly lower risk of developmental disorders in children compared

Smaller gene-editing system could expand treatment options for cancer, ALS and other diseases A

Bernice Wright, lecturer in cell and gene therapy at UCL, says “We must highlight opportunities available so that more women,

NIH-supported clinical trial shows coordinated care strategy more effective than standard care A clinical

Two new vaccines to prevent tuberculosis (TB) are safe for use in adults and